Safety and Efficacy of AlphaWave® l-Theanine Supplementation for 28 Days in Healthy Adults with Moderate Stress: A Randomized, Double-Blind, Placebo-Controlled Trial
Open accessThe DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index; 6 of the 38 sources its claims cite were checked for support.
Abstract
Prolonged periods of stress may lead to negative health consequences. AlphaWave ® l -Theanine was safe and efficacious during an acute stress challenge. However, double-blind, placebo-controlled clinical trials investigating the longer term effects of l -theanine supplementation on stress are warranted. Thirty healthy adults (18–65 years) with moderate stress were randomized to AlphaWave ® l -Theanine (400 mg l -theanine/day) or placebo ( n = 15/group) for 28 days. Stress was assessed by salivary cortisol, Perceived Stress Scale (PSS) and Depression, Anxiety and Stress Scale-21; sleep was assessed by the Healthy People Sleep Quality Index and actigraphy device; cognition was assessed by Computerized Mental Performance Assessment System; mood was assessed by Profile of Mood States. All outcomes were measured at baseline, Days 14 and 28. Safety included vital signs, clinical chemistry, haematology and adverse events (AEs). All AEs were resolved by the end of the study period or upon subsequent follow up, and out of range laboratory values and changes in vital signs were deemed not clinically relevant following AlphaWave ® l -Theanine supplementation. Participants supplemented with AlphaWave ® l -Theanine had decreases of 12.92% ( p = 0.051) and 17.98% ( p = 0.04) in PSS scores after 14 and 28 days, respectively, while those on placebo had respective decreases of 9.74% ( p = 0.061) and 17.88% ( p = 0.009). There were no significant differences between groups for change in salivary cortisol. The AlphaWave ® l -Theanine group demonstrated decreased time asleep after 28 days and significantly reduced light sleep after 14 and 28 days compared to placebo ( p ≤ 0.040). The AlphaWave ® l -Theanine group significantly improved by 21.79% and 21.33% in Stroop test correct reaction time after 14 and 28 days, respectively, while those on placebo improved after 28 days only ( p = 0.005). AlphaWave ® l -Theanine supplementation for 28 days was safe and significantly decreased perceived stress significantly decreased perceived stress and light sleep, improved sleep quality and enhanced cognitive attention in the studied population. Larger, randomized controlled trials with longer duration of AlphaWave ® l -Theanine supplementation are warranted to reduce inter-individual variability and the potential placebo effect. ClinicalTrials.gov identifier, NCT05808595.
Overview
CoChat Summary
TL;DR
In a 28-day randomized, double-blind, placebo-controlled trial in 30 healthy adults with moderate stress, AlphaWave® l-theanine (400 mg/day) was safe and well tolerated. It significantly reduced PSS scores from baseline and light sleep versus placebo and improved Stroop correct reaction time from baseline, but there were no significant between-group differences for PSS or salivary cortisol, and placebo also improved on several measures.
Key findings
- Safety: 9 adverse events (AEs) were reported by 6 participants; 8 AEs occurred in 5 AlphaWave® l-theanine participants and 1 in a placebo participant. Two AlphaWave® AEs (metallic taste, dry mouth) were mild and possibly related; all AEs resolved, and no clinically relevant vital sign or laboratory changes were found.
- Perceived stress: AlphaWave® l-theanine decreased PSS scores from baseline at Day 14 (p = 0.051) and Day 28 (p = 0.04); placebo decreased at Day 14 (p = 0.061) and Day 28 (p = 0.009). There were no significant between-group differences, and no significant between-group differences in salivary cortisol.
- Sleep: AlphaWave® l-theanine showed decreased time asleep at Day 28 versus placebo (change −29.62 ± 51.77 vs. +18.11 ± 63.29 min; p = 0.032) and reduced light sleep at Days 14 and 28 versus placebo (p = 0.040 and p = 0.026). No significant between-group differences were found for HPSQI subjective sleep data.
- Cognition/mood: AlphaWave® l-theanine improved Stroop correct reaction time from baseline at Day 14 (p = 0.037) and Day 28 (p = 0.013); placebo improved at Day 28 only (p = 0.005), with no significant between-group RT differences. DASS-21 total and stress subscale scores decreased more in placebo at Day 28 (p = 0.017 and p = 0.012), and there were no significant between-group POMS differences.
Methods
- Randomized, double-blind, placebo-controlled, parallel trial with a 7-day run-in and 28-day supplementation period; 30 healthy adults aged 18–65 with moderate stress (PSS 14–26) were randomized n = 15/group to AlphaWave® l-theanine 400 mg/day (200 mg twice daily) or placebo.
- Primary outcome was salivary cortisol; secondary outcomes included PSS, DASS-21, Healthy People Sleep Quality Index, actigraphy, COMPASS cognition, and POMS mood at baseline, Days 14 and 28; safety included AEs, vital signs, clinical chemistry, and haematology.
- Analyses used the intention-to-treat/safety population in R 4.2.1; between-group differences used two-sample t-test, Wilcoxon rank sum, or Fisher’s exact test, and within-group differences used paired t-test or Wilcoxon signed rank test, with p ≤ 0.05 considered significant.
Limitations
- Stated: the sample was primarily female, limiting generalizability; larger samples and longer trials are needed to reduce inter-individual variability and assess whether the placebo effect wanes; salivary cortisol may be confounded by sampling timing, light exposure, sleep changes, or prior-day stress; PSS and DASS-21 findings conflicted.
- Evident: baseline imbalances existed between groups (morning salivary cortisol higher in placebo, p = 0.028; time asleep higher in AlphaWave® l-theanine, p = 0.049; Stroop accuracy differences at baseline, p = 0.039), which may complicate interpretation of between-group changes.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
6 Valid · 0 Not valid · 26 Not checked · 82 Own results and interpretations
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Other studies examining l-theanine have also shown improvements in markers of stress among healthy populations in acute [9, 10] and chronic [11, 12] settings.”
§ Safety and Efficacy of AlphaWave® l-Theanine Supplementation for 28 Days in Healthy Adults with Moderate Stress: A Randomized, Double-Blind, Placebo-Controlled Trial > Introduction
What the sources say
- Not checked yetcites [11] Unno K, Tanida N, Ishii N, Yamamoto H, Iguchi K, Hoshino M, Takeda A, Ozawa H, Ohkubo T, Juneja LR. Anti-stress effect of theanine on students during pharmacy practice: positive correlation among salivary α-amylase activity, trait anxiety and subjective stress. Pharmacol Biochem Behav. 2013;111:128–35. source
- Supportedcites [12] Hidese S, Ogawa S, Ota M, Ishida I, Yasukawa Z, Ozeki M, Kunugi H. Effects of l-theanine administration on stress-related symptoms and cognitive functions in healthy adults: a randomized controlled trial. Nutrients. 2019;11(10):2362. source
The Discussion (p.1) of our copy reports that stress-related symptoms assessed with SDS, STAI-T and PSQI scores decreased following four weeks (i.e., chronic) L-theanine administration in a healthy population, stating 'this trial suggests, for the first time, that 4 weeks L-theanine administration is effective in improving stress-related symptoms in healthy adults.' The Introduction (p.1) confirms the population was healthy adults without major psychiatric disorder and that the design was a randomized, placebo-controlled, double-blind trial of 200 mg/day for four weeks, and the Conclusions restate the reductions in depression, trait-anxiety and sleep scores. A minor caveat is that objective stress biomarkers (salivary cortisol and IgA) did not change significantly, but the claim's 'markers of stress' is carried by the symptom scales the paper measures. (LLM, conf=0.88)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“l-Theanine is a water-soluble, non-protein amino acid predominantly found in green tea leaves that has been shown as an emerging option for stress management [6].”
§ Safety and Efficacy of AlphaWave® l-Theanine Supplementation for 28 Days in Healthy Adults with Moderate Stress: A Randomized, Double-Blind, Placebo-Controlled Trial > Introduction
What the sources say
- Partly supportedcites [6] Sakato Y. The chemical constituents of tea; III. A new amide theanine. Nippon Nogeikagaku Kaishi. 1949;23:262–7. sourceExperimental — accuracy not yet measured
Our copy of Sakata (1950) supports the descriptive half of the sentence: the Summary (Additional information) states theanine was isolated from the water extract of Japanese green tea, is 'very soluble in water... but insoluble in ethyl alcohol and ether', and that 'Gyokuro is rich (about 1%) in it, but Sencha is poor' — i.e. a tea-leaf constituent outside protein metabolism (it gives L-glutamic acid and ethyl amine on hydrolysis, and 'assumes the analogous role of glutamine or asparagine in other plants'). However, nothing in our copy attributes any stress-relieving or anxiolytic property to theanine: the only 'physiology' discussed is PLANT physiology (Abstract, e.g. theanine's role in nitrogen storage/metabolism in the tea bush, and the statement that its destination of ethyl amine is unknown). The claim's core assertion — 'shown as an emerging option for stress management' — is not in this 1950 isolation paper, so the citation supports the identity/solubility/source of theanine but not the stress-management point. (LLM, conf=0.80)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Previously, AlphaWave® l-Theanine supplementation demonstrated significantly greater increases in alpha power, a surrogate marker of relaxation, compared to placebo when moderately stressed adults were faced with an acute stress challenge [8].”
- Also stated in: § Key Summary Points · boosted
“AlphaWave® l-Theanine has been previously shown to significantly increase alpha power, a surrogate marker of relaxation, compared to placebo, when moderately stressed adults were faced with an acute stress challenge”
§ Safety and Efficacy of AlphaWave® l-Theanine Supplementation for 28 Days in Healthy Adults with Moderate Stress: A Randomized, Double-Blind, Placebo-Controlled Trial > Introduction
What the sources say
- Supportedcites [8] Evans M, McDonald AC, Xiong L, Crowley DC, Guthrie N. A randomized, triple-blind, placebo-controlled, crossover study to investigate the efficacy of a single dose of AlphaWave® l-theanine on stress in a healthy adult population. Neurol Ther. 2021;10(2):1061–78. source
The Key Summary Points table states the objective was to determine the efficacy of AlphaWave® l-Theanine on whole-scalp and frontal alpha power (indicators of relaxation) in moderately stressed adults using an acute stress model, and that a single dose led to a greater increase in alpha power 3 h post-dose versus placebo. The Results (EEG) sections give the significance: a significantly greater between-group increase in frontal region alpha power at 3 h (p = 0.038) and a significant between-group increase in whole-scalp alpha power during the eyes-open portion (p = 0.050). The Conclusions tie this to relaxation in moderately stressed but otherwise healthy adults facing the acute (MAT) stressor, matching the claim's paraphrase (only 'supplementation' vs. the study's single 200 mg dose differs trivially in level). (LLM, conf=0.90)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Key Summary Points · boosted
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Other studies examining l-theanine have also shown improvements in markers of stress among healthy populations in acute [9, 10] and chronic [11, 12] settings.”
§ Safety and Efficacy of AlphaWave® l-Theanine Supplementation for 28 Days in Healthy Adults with Moderate Stress: A Randomized, Double-Blind, Placebo-Controlled Trial > Introduction
What the sources say
- Not checked yetcites [9] Kimura K, Ozeki M, Juneja LR, Ohira H. l-Theanine reduces psychological and physiological stress responses. Biol Psychol. 2007;74(1):39–45. source
- Supportedcites [10] White DJ, De Klerk S, Woods W, Gondalia S, Noonan C, Scholey AB. Anti-stress, behavioural and magnetoencephalography effects of an l-theanine-based nutrient drink: a randomised, double-blind, placebo-controlled, crossover trial. Nutrients. 2016;8(1):53. source
The Abstract (p. 1) reports that in this randomised, double-blind, placebo-controlled crossover trial in 34 healthy adults, a single (acute) dose of an l-theanine-based drink significantly reduced subjective stress response to a multitasking cognitive stressor and reduced the salivary cortisol response three hours post-dose, concluding that the findings 'further support the anti-stress effects of l-theanine'. The Discussion (p. ~12) likewise frames the study as providing 'additional support for an anxiolytic or anti-stress effect of l-theanine administration' alongside 'previous reports of acute anti-stress effects'. This matches the cited point: an l-theanine study showing improved stress markers in a healthy population under acute conditions. (LLM, conf=0.90)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There were no other significant between-group differences in total and stress subscale DASS-21 scores.”
§ Safety and Efficacy of AlphaWave® l-Theanine Supplementation for 28 Days in Healthy Adults with Moderate Stress: A Randomized, Double-Blind, Placebo-Controlled Trial > Results > Depression, Anxiety and Stress Scale
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
53 more claims
Create a free account to see all 114 claims and to verify the 32 references still open.
- Probably not a substantial claim. 38
- It may state two separate claims as one. 30
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“However, inconsistent results in other studies involving healthy adult samples suggest further high-quality trials on this topic would be useful (36–38).”
From Effects of L-theanine on cognition, mood and sleep: evidence from human trials (2026) · cites this paper as [38]
Citations
Cites
A Global Measure of Perceived Stress
Cohen, S., Kamarck, T., & Mermelstein, R. (1983) · Journal of Health and Social Behavior · doi:10.2307/2136404 · Cited by 32,807 · cited 1×
“The PSS is an assessment of how much an individual perceives life to be unpredictable and uncontrollable [32] whereas the DASS-21 stress subscale is more focused on assessing symptoms such as difficulty relaxing, nervous arousal and irritability [15].”
BackgroundMoher, D., Hopewell, S., Schulz, K. F., Montori, V., Gotzsche, P. C., Devereaux, P. J., Elbourne, D., Egger, M., & Altman, D. G. (2010) · BMJ · doi:10.1136/bmj.c869 · Cited by 8,883 · cited 1×
“Consolidated Standards of Reporting Trials (CON-SORT) guidelines for randomized controlled trials were followed [13] (Table S1), and written informed consent was obtained from all participants prior to participation in the study.”
Method(1988) · Cited by 4,111
Moher, D., Hopewell, S., Schulz, K. F., Montori, V., Gøtzsche, P. C., Devereaux, P. J., Elbourne, D., Egger, M., & Altman, D. G. (2012) · International Journal of Surgery · doi:10.1016/j.ijsu.2011.10.001 · Cited by 2,345
Stress and Quality of Life Among University Students: A Systematic Literature Review
Ribeiro, Í. J. S., Pereira, R., Freire, I. V., de Oliveira, B. G., Casotti, C. A., & Boery, E. N. (2018) · Health Professions Education · doi:10.1016/j.hpe.2017.03.002 · Cited by 684 · cited 1×
“A decrease in stress is important for this population as an inverse association between stress and quality of life has been reported previously [21] suggesting AlphaWave ® l -Theanine supplementation may represent a strategy to improve quality of life.”
Backgroundl-theanine reduces psychological and physiological stress responses
Kimura, K., Ozeki, M., Juneja, L. R., & Ohira, H. (2007) · Biological Psychology · doi:10.1016/j.biopsycho.2006.06.006 · Cited by 349 · cited 1×
“Other studies examining l -theanine have also shown improvements in markers of stress among healthy populations in acute [9, 10] and chronic [11, 12] settings.”
ResultHansen, Å. M., Garde, A. H., & Persson, R. (2008) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365510701819127 · Cited by 198 · cited 1×
“There are many factors that may confound salivary cortisol measurements such as time of sampling, vigorous exercise, food intake, light exposure and prior day and/or imminent challenges or stressful events [26, 27].”
BackgroundHidese, S., Ogawa, S., Ota, M., Ishida, I., Yasukawa, Z., Ozeki, M., & Kunugi, H. (2019) · Nutrients · doi:10.3390/nu11102362 · Cited by 170 · cited 2×
“Other studies examining l -theanine have also shown improvements in markers of stress among healthy populations in acute [9, 10] and chronic [11, 12] settings.”
ResultWightman, E. L., Haskell-Ramsay, C. F., Thompson, K. G., Blackwell, J. R., Winyard, P. G., Forster, J., Jones, A. M., & Kennedy, D. O. (2015) · Physiology & Behavior · doi:10.1016/j.physbeh.2015.05.035 · Cited by 170 · cited 1×
“Computerized Mental Performance Assessment System COMPASS is used to assess cognitive function and has been reported to be sensitive to nutritional interventions [16, 17].”
MethodStudies on the Chemical Constituents of Tea
SAKATO, Y. (1950) · Journal of the agricultural chemical society of Japan · doi:10.1271/nogeikagaku1924.23.262 · Cited by 148
Cited by
The effects of L-theanine consumption on sleep outcomes: a systematic review and meta-analysis
Bulman, A., D’Cunha, N. M., Marx, W., Turner, M., McKune, A., & Naumovski, N. (2025) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2025.102076 · Cited by 20
Moshfeghinia, R., Sanaei, E., Mostafavi, S., Assadian, K., Sanaei, A., & Ayano, G. (2024) · BMC Psychiatry · doi:10.1186/s12888-024-06285-y · Cited by 17
Examining the effect of L-theanine on sleep: a systematic review of dietary supplementation trials
Cotter, J., Caddick, C. E., Harper, J. L., & Ebajemito, J. K. (2026) · Nutritional Neuroscience · doi:10.1080/1028415x.2025.2556925 · Cited by 5
“Where reported, dosing adherence was high and was supported by elevated serum L-theanine concentrations [26,37,41,43].”
InfluentialShi, Y., Yang, Y., Cheng, X. R., Huang, C., Huang, Y., Lu, L., Wang, S., Zheng, Y., Wang, F., Zhang, B., et al. (2026) · Foods · doi:10.3390/foods15030555 · Cited by 2
Effect of L-theanine on the hippocampus, cerebral cortex and cerebellum of doxorubicin-treated rats
Kural, B. V., Kör, S., Malkoç, M. A., ÖZTÜRK, H., Durmus, T. B., Yuluğ, E., Aydın-Abidin, S., Abidin, İ., & Örem, A. (2025) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2025.153216 · Cited by 1
Metadata
- Authors
- Moulin, M., Crowley, D. C., Xiong, L., Guthrie, N., & Lewis, E. D.
- Corresponding author
- Lewis, Erin D.
- ORCID
- Lewis, Erin D.
- Venue
- Neurology and Therapy
- Published
- 2024-05-17
- Volume
- 13
- Issue
- 4
- Pages
- 1135-1153
- ISSN
- 2193-6536 (ISSN-L)
- 2193-8253
- PMC
- PMC11263523
- OpenAlex
- W4397006913
- Cited by
- 14
- References
- 26
- Citations by year
- 2026: 9 · 2025: 4 · 2024: 1
- FWCI
- 7.00
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc
- creativecommons.org/licenses/by-nc/4.0 (tdm)
- creativecommons.org/licenses/by-nc/4.0 (vor)
- Locations
- Neurology and Therapy (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- Ethical Naturals, Inc.
- Topics
- Health Sciences › Medicine › Complementary and alternative medicine › Medicinal Plant Extracts Effects
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Health Sciences › Medicine › Complementary and alternative medicine › Medicinal Plants and Bioactive Compounds
- Keywords
- theanine, dietary supplementation, acute stress, perceived stress, salivary cortisol, sleep quality, light sleep, cognitive performance, Stroop task, mood, adverse events, safety, healthy adults, actigraphy, Profile of Mood States, DASS-21, PSS, cognitive flexibility, reaction time
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-05, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-05 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Safety and Efficacy of AlphaWave® l-Theanine Supplementation for 28 Days in Healthy Adults with Moderate Stress: A Randomized, Double-Blind, Placebo-Controlled Trial. https://app.cochat.ai/papers/10.1007/s40120-024-00624-7
- The paper
- Moulin, M., Crowley, D. C., Xiong, L., Guthrie, N., & Lewis, E. D. (2024). Safety and Efficacy of AlphaWave® l-Theanine Supplementation for 28 Days in Healthy Adults with Moderate Stress: A Randomized, Double-Blind, Placebo-Controlled Trial. Neurology and Therapy. https://doi.org/10.1007/s40120-024-00624-7
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.